Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock suffered a major decline of -13.3% on 11/15/24. The shares closed at $18.57. Moreover, unusually high trading volume at 176% of normal accompanied the decline. The stock has been weak relative to the market over the last nine months and has declined -13.2% during the last week.
Current PriceTarget Research Rating
Arrowhead Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Arrowhead Pharmaceuticals has a very low Appreciation Score of 7 and a very low Power Rating of 5, triggering the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment